AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 587 businesses audited.
Amgen has 17.8 points less BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: Amgen (amgen.com)
Amgen is a rare example of a corporate giant that uses marketing cliches as a wrapper for genuine technical substance. While the site lacks modern structured data, the narrative content is anchored by specific scientific milestones and third-party ethical audits that are current to May 2026.
Immediate implementation of Organization and Person schema is required to bridge the technical authority gap. Add specific regulatory identifiers (such as FDA 510(k) or ClinicalTrials.gov IDs) directly into the Pipeline and Product section headings. Direct links to peer-reviewed citations should be placed next to bold claims like the 3-million-fracture goal. Replace generic H2 labels like ‘Our Science’ and ‘Our Products’ with more descriptive, noun-heavy headings that reflect their current breakthrough focus areas.
The site exhibits high substance density, particularly in its sub-pages. While the homepage uses some power words like ‘World-class’ and ‘Pioneer’ in the H1, the body text quickly transitions to specific named entities such as ‘Shannon Turley’ and technical concepts like ‘AI-Enabled Clinical Development’ and ‘Lp(a)’. Specificity is high, with more than 8 distinct technical or named evidence points across the crawled sections, significantly reducing the fluff score.
Hydration, modals, and JS dependent content erase entire sections of your page before AI can read them. Audit your AI visible surface to see what survives a script free crawl.
Alignment between the homepage and sub-pages is excellent. The homepage H1 ‘A Worldwide Pioneer in Biotechnology’ is directly supported by the ‘Our Science’ sub-page, which details a robust R&D strategy and manufacturing capabilities for biosimilars. There is no discernible drift between high-level promises and the technical depth of the internal sections.
Stop the ROI leak caused by technical debt and strategic misalignment. Conduct an Independent Strategic Diagnosis for 1 Euro to identify high impact issues across all audit categories.
The trust_theatre_flag is false across all analyzed pages, and the site avoids generic review aggregators. Most ‘trust signals’ are actually dated news items regarding third-party recognitions like ‘Newsweek’s Most Trustworthy Companies 2026’ and ‘Ethisphere’s Most Ethical Companies 2026.’ However, the proof_links_count remains low at 2 per page, suggesting that while the claims are specific, the direct path to external raw data is limited in the surface-level crawl.
The ratio of evidence to assertions is high. For every generic claim about ‘innovation,’ there is a corresponding specific story about a therapeutic area (e.g., ‘The Genetic Puzzle of Heart Disease’) or a specific lab methodology (‘Small Molecule Drug Discovery’). This results in a low BS score for proof density.
For a demonstration of entity driven retail architecture, open the Walmart Structured Data audit. View the Walmart Structured Data Audit to see how product, brand, and service entities are reconstructed for AI systems.
The site contains several matches for industry cliches including ‘transforming patient outcomes,’ ‘pioneering medical science,’ and ‘innovation for life.’ Despite this, the unique focus on ‘AI-enabled clinical development’ and specific disease pathways like KRAS prevents the value proposition from being entirely commoditized. The template sections like ‘Our Science’ and ‘Our Products’ are generic in title but contain highly specific content.
A notable technical gap is the absence of structured data (schema_json is null across all pages), which is unexpected for a company positioning itself at the intersection of biology and technology. While the site names experts like Shannon Turley and CEO Bob Bradway, there is no Person schema or sameAs linking to verify their digital footprint within the technical metadata.
There is a minor disconnect regarding the claim of ‘reaching millions of patients’ and the ‘3 Million Fractures’ goal, as these are presented as marketing headlines without immediate, on-page links to the underlying statistical reports or longitudinal studies. However, the mention of specific Q1 2026 earnings reports provides a temporal anchor for financial and operational claims.
Medical Devices, Pharma & Biotech BS: Amgen (amgen.com)
Amgen perfectly aligns with the Biotechnology and Pharmaceuticals industry classification, with content heavily focused on R&D strategy, clinical trial management, and specific therapeutic areas. The presence of technical jargon such as ‘biosimilars,’ ‘KRAS,’ and ‘IgG4-RD’ confirms a high-fidelity industry match.
AI does not interpret your layout visually — it interprets your structure mathematically. Explore the Semantic HTML Technical Framework to understand how heading logic, boundaries, and DOM depth determine what an LLM can retrieve.
“The score of 23 was primarily driven by the absence of schema (Identity/Authority) and the use of common pharma cliches (Commodity Fingerprint). Information density and semantic coherence are exceptionally strong, keeping the total score in the 'Minimal BS' range.”